Mumbai: Mercury Laboratories Ltd reported an 88.08 per cent increase in standalone net profit to ₹39.19 crore for the quarter ended 30 June 2026, compared to ₹20.84 crore in the corresponding period last year.
Financial Performance
Revenue from operations for the quarter stood at ₹1,596.32 crore, up from ₹1,044.24 crore in the previous year's first quarter. Total income for Q1 FY27 reached ₹1,601.54 crore, marking a significant rise from ₹1,070.09 crore in Q1 FY26.
Expenses and Profitability
Total expenses for the quarter ended 30 June 2026 were ₹1,562.35 crore, compared to ₹1,040.64 crore in the same quarter last year. Earnings per share (EPS) for the current quarter improved to ₹2.48, from ₹1.30 in Q1 FY26.
Board Meeting Outcome
The company's Board of Directors met on 25 July 2026 and approved the unaudited standalone financial results. The meeting commenced at 9:30 a.m. IST and concluded at 11:33 a.m. IST.
Auditor's Review
The financial results were subject to a 'Limited Review' by the statutory auditors. The auditors' report indicated no material misstatement in the accompanying standalone financial statement.
Disclaimer: This report is based on the company's filed financial results (standalone or consolidated, as applicable) and is intended solely for informational purposes. It does not constitute investment advice or a recommendation to buy, sell or hold any security.
